Representative LC/UV chromatogram under typical analytical conditions (C18 column; mobile phase: 60–100% ACN / H2O (0.05% H3PO4), linear gradient 20 min; flow rate: 0.2 mL/min; detection: 210 nm).
NMR Spectral Data
Representative 1H NMR (500 MHz) spectrum confirming the structure of Elasnin. Representative 13C NMR (125 MHz) spectrum supporting structural assignment of Elasnin.
Source Organism
Streptomyces sp.
Summary
Elasnin is a Streptomyces-derived elastase inhibitor with potent antibiofilm activity against MRSA.
Details
Elasnin is a polyketide-derived metabolite isolated from Streptomyces noboritoensis and originally identified as a selective inhibitor of human granulocyte elastase. It inhibits human elastase at low micromolar concentrations while showing minimal activity against related serine proteases. More recently, elasnin has been shown to eradicate methicillin-resistant Staphylococcus aureus (MRSA) biofilms, including daptomycin-resistant strains, by disrupting biofilm matrix integrity and repressing cell division, cell wall synthesis, and virulence-associated pathways. Multi-omics analyses indicate interference with key regulatory systems and biofilm maintenance mechanisms, highlighting its potential as a biofilm-targeting anti-virulence agent.